TAMELLA LIVENGOOD: Open Payments
NPI 1407038151 · TRAVERSE CITY, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$965 in 39 payments from 14 companies in 2025. Trend: 2023 $122 · 2024 $227 · 2025 $965
Food & beverage: $905Education: $60
| Company | Payments | Amount |
|---|---|---|
| Astellas Pharma US Inc | 6 | $172 |
| Novo Nordisk Inc | 3 | $166 |
| ABBVIE INC. | 8 | $150 |
| AstraZeneca Pharmaceuticals LP | 7 | $128 |
| PFIZER INC. | 5 | $100 |
| Inspire Medical Systems, Inc. | 1 | $55 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $51 |
| Exact Sciences Corporation | 1 | $24 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $22 |
| Axsome Therapeutics, Inc. | 1 | $22 |
Products named: Wegovy, Veozah, AIRSUPRA, QULIPTA, INSPIRE, CAPLYTA, VRAYLAR, UBRELVY.
Industry payments across MI — which companies pay providers there.
